In this week’s patent news: After Natco, Bajaj Healthcare files compulsory license application against Eli Lilly for Baricitinib; EPO Enlarged Board of Appeal issues Decision...
Read more about After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more